ArticleMolecular cancer2024

Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.

Sophie Poulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.